Medical Care
Global Human Oocyte Cryopreservation Market Research Report 2025
- Nov 04, 25
- ID: 223591
- Pages: 99
- Figures: 99
- Views: 37
This report aims to provide a comprehensive presentation of the global market for Human Oocyte Cryopreservation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Oocyte Cryopreservation.
The Human Oocyte Cryopreservation market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Oocyte Cryopreservation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Oocyte Cryopreservation companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Anova Fertility
CCRM IVF
Chill
CREATE Fertility
Extend Fertility
HRC Fertility
IVF Australia
Kindbody
London Women’s Clinic
Manchester Fertility
Mayo Clinic
Melbourne IVF
Monash IVF
Pacific Fertility Center-Los Angeles (PFCLA)
PIVET
Prelude Fertility
Segment by Type
Slow-cooling Method
Flash-freezing Process (Vitrification)
Segment by Application
25-30 Year Old Female
30-35 Year Old Female
35-40 Year Old Female
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Oocyte Cryopreservation company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Human Oocyte Cryopreservation market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Oocyte Cryopreservation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Oocyte Cryopreservation companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Anova Fertility
CCRM IVF
Chill
CREATE Fertility
Extend Fertility
HRC Fertility
IVF Australia
Kindbody
London Women’s Clinic
Manchester Fertility
Mayo Clinic
Melbourne IVF
Monash IVF
Pacific Fertility Center-Los Angeles (PFCLA)
PIVET
Prelude Fertility
Segment by Type
Slow-cooling Method
Flash-freezing Process (Vitrification)
Segment by Application
25-30 Year Old Female
30-35 Year Old Female
35-40 Year Old Female
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Oocyte Cryopreservation company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Oocyte Cryopreservation Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Slow-cooling Method
1.2.3 Flash-freezing Process (Vitrification)
1.3 Market by Application
1.3.1 Global Human Oocyte Cryopreservation Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 25-30 Year Old Female
1.3.3 30-35 Year Old Female
1.3.4 35-40 Year Old Female
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human Oocyte Cryopreservation Market Perspective (2020-2031)
2.2 Global Human Oocyte Cryopreservation Growth Trends by Region
2.2.1 Global Human Oocyte Cryopreservation Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Human Oocyte Cryopreservation Historic Market Size by Region (2020-2025)
2.2.3 Human Oocyte Cryopreservation Forecasted Market Size by Region (2026-2031)
2.3 Human Oocyte Cryopreservation Market Dynamics
2.3.1 Human Oocyte Cryopreservation Industry Trends
2.3.2 Human Oocyte Cryopreservation Market Drivers
2.3.3 Human Oocyte Cryopreservation Market Challenges
2.3.4 Human Oocyte Cryopreservation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Oocyte Cryopreservation Players by Revenue
3.1.1 Global Top Human Oocyte Cryopreservation Players by Revenue (2020-2025)
3.1.2 Global Human Oocyte Cryopreservation Revenue Market Share by Players (2020-2025)
3.2 Global Top Human Oocyte Cryopreservation Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Human Oocyte Cryopreservation Revenue
3.4 Global Human Oocyte Cryopreservation Market Concentration Ratio
3.4.1 Global Human Oocyte Cryopreservation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Oocyte Cryopreservation Revenue in 2024
3.5 Global Key Players of Human Oocyte Cryopreservation Head office and Area Served
3.6 Global Key Players of Human Oocyte Cryopreservation, Product and Application
3.7 Global Key Players of Human Oocyte Cryopreservation, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Oocyte Cryopreservation Breakdown Data by Type
4.1 Global Human Oocyte Cryopreservation Historic Market Size by Type (2020-2025)
4.2 Global Human Oocyte Cryopreservation Forecasted Market Size by Type (2026-2031)
5 Human Oocyte Cryopreservation Breakdown Data by Application
5.1 Global Human Oocyte Cryopreservation Historic Market Size by Application (2020-2025)
5.2 Global Human Oocyte Cryopreservation Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Human Oocyte Cryopreservation Market Size (2020-2031)
6.2 North America Human Oocyte Cryopreservation Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Human Oocyte Cryopreservation Market Size by Country (2020-2025)
6.4 North America Human Oocyte Cryopreservation Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Human Oocyte Cryopreservation Market Size (2020-2031)
7.2 Europe Human Oocyte Cryopreservation Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Human Oocyte Cryopreservation Market Size by Country (2020-2025)
7.4 Europe Human Oocyte Cryopreservation Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Human Oocyte Cryopreservation Market Size (2020-2031)
8.2 Asia-Pacific Human Oocyte Cryopreservation Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Human Oocyte Cryopreservation Market Size by Region (2020-2025)
8.4 Asia-Pacific Human Oocyte Cryopreservation Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Human Oocyte Cryopreservation Market Size (2020-2031)
9.2 Latin America Human Oocyte Cryopreservation Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Human Oocyte Cryopreservation Market Size by Country (2020-2025)
9.4 Latin America Human Oocyte Cryopreservation Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Oocyte Cryopreservation Market Size (2020-2031)
10.2 Middle East & Africa Human Oocyte Cryopreservation Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Human Oocyte Cryopreservation Market Size by Country (2020-2025)
10.4 Middle East & Africa Human Oocyte Cryopreservation Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Anova Fertility
11.1.1 Anova Fertility Company Details
11.1.2 Anova Fertility Business Overview
11.1.3 Anova Fertility Human Oocyte Cryopreservation Introduction
11.1.4 Anova Fertility Revenue in Human Oocyte Cryopreservation Business (2020-2025)
11.1.5 Anova Fertility Recent Development
11.2 CCRM IVF
11.2.1 CCRM IVF Company Details
11.2.2 CCRM IVF Business Overview
11.2.3 CCRM IVF Human Oocyte Cryopreservation Introduction
11.2.4 CCRM IVF Revenue in Human Oocyte Cryopreservation Business (2020-2025)
11.2.5 CCRM IVF Recent Development
11.3 Chill
11.3.1 Chill Company Details
11.3.2 Chill Business Overview
11.3.3 Chill Human Oocyte Cryopreservation Introduction
11.3.4 Chill Revenue in Human Oocyte Cryopreservation Business (2020-2025)
11.3.5 Chill Recent Development
11.4 CREATE Fertility
11.4.1 CREATE Fertility Company Details
11.4.2 CREATE Fertility Business Overview
11.4.3 CREATE Fertility Human Oocyte Cryopreservation Introduction
11.4.4 CREATE Fertility Revenue in Human Oocyte Cryopreservation Business (2020-2025)
11.4.5 CREATE Fertility Recent Development
11.5 Extend Fertility
11.5.1 Extend Fertility Company Details
11.5.2 Extend Fertility Business Overview
11.5.3 Extend Fertility Human Oocyte Cryopreservation Introduction
11.5.4 Extend Fertility Revenue in Human Oocyte Cryopreservation Business (2020-2025)
11.5.5 Extend Fertility Recent Development
11.6 HRC Fertility
11.6.1 HRC Fertility Company Details
11.6.2 HRC Fertility Business Overview
11.6.3 HRC Fertility Human Oocyte Cryopreservation Introduction
11.6.4 HRC Fertility Revenue in Human Oocyte Cryopreservation Business (2020-2025)
11.6.5 HRC Fertility Recent Development
11.7 IVF Australia
11.7.1 IVF Australia Company Details
11.7.2 IVF Australia Business Overview
11.7.3 IVF Australia Human Oocyte Cryopreservation Introduction
11.7.4 IVF Australia Revenue in Human Oocyte Cryopreservation Business (2020-2025)
11.7.5 IVF Australia Recent Development
11.8 Kindbody
11.8.1 Kindbody Company Details
11.8.2 Kindbody Business Overview
11.8.3 Kindbody Human Oocyte Cryopreservation Introduction
11.8.4 Kindbody Revenue in Human Oocyte Cryopreservation Business (2020-2025)
11.8.5 Kindbody Recent Development
11.9 London Women’s Clinic
11.9.1 London Women’s Clinic Company Details
11.9.2 London Women’s Clinic Business Overview
11.9.3 London Women’s Clinic Human Oocyte Cryopreservation Introduction
11.9.4 London Women’s Clinic Revenue in Human Oocyte Cryopreservation Business (2020-2025)
11.9.5 London Women’s Clinic Recent Development
11.10 Manchester Fertility
11.10.1 Manchester Fertility Company Details
11.10.2 Manchester Fertility Business Overview
11.10.3 Manchester Fertility Human Oocyte Cryopreservation Introduction
11.10.4 Manchester Fertility Revenue in Human Oocyte Cryopreservation Business (2020-2025)
11.10.5 Manchester Fertility Recent Development
11.11 Mayo Clinic
11.11.1 Mayo Clinic Company Details
11.11.2 Mayo Clinic Business Overview
11.11.3 Mayo Clinic Human Oocyte Cryopreservation Introduction
11.11.4 Mayo Clinic Revenue in Human Oocyte Cryopreservation Business (2020-2025)
11.11.5 Mayo Clinic Recent Development
11.12 Melbourne IVF
11.12.1 Melbourne IVF Company Details
11.12.2 Melbourne IVF Business Overview
11.12.3 Melbourne IVF Human Oocyte Cryopreservation Introduction
11.12.4 Melbourne IVF Revenue in Human Oocyte Cryopreservation Business (2020-2025)
11.12.5 Melbourne IVF Recent Development
11.13 Monash IVF
11.13.1 Monash IVF Company Details
11.13.2 Monash IVF Business Overview
11.13.3 Monash IVF Human Oocyte Cryopreservation Introduction
11.13.4 Monash IVF Revenue in Human Oocyte Cryopreservation Business (2020-2025)
11.13.5 Monash IVF Recent Development
11.14 Pacific Fertility Center-Los Angeles (PFCLA)
11.14.1 Pacific Fertility Center-Los Angeles (PFCLA) Company Details
11.14.2 Pacific Fertility Center-Los Angeles (PFCLA) Business Overview
11.14.3 Pacific Fertility Center-Los Angeles (PFCLA) Human Oocyte Cryopreservation Introduction
11.14.4 Pacific Fertility Center-Los Angeles (PFCLA) Revenue in Human Oocyte Cryopreservation Business (2020-2025)
11.14.5 Pacific Fertility Center-Los Angeles (PFCLA) Recent Development
11.15 PIVET
11.15.1 PIVET Company Details
11.15.2 PIVET Business Overview
11.15.3 PIVET Human Oocyte Cryopreservation Introduction
11.15.4 PIVET Revenue in Human Oocyte Cryopreservation Business (2020-2025)
11.15.5 PIVET Recent Development
11.16 Prelude Fertility
11.16.1 Prelude Fertility Company Details
11.16.2 Prelude Fertility Business Overview
11.16.3 Prelude Fertility Human Oocyte Cryopreservation Introduction
11.16.4 Prelude Fertility Revenue in Human Oocyte Cryopreservation Business (2020-2025)
11.16.5 Prelude Fertility Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Oocyte Cryopreservation Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Slow-cooling Method
1.2.3 Flash-freezing Process (Vitrification)
1.3 Market by Application
1.3.1 Global Human Oocyte Cryopreservation Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 25-30 Year Old Female
1.3.3 30-35 Year Old Female
1.3.4 35-40 Year Old Female
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human Oocyte Cryopreservation Market Perspective (2020-2031)
2.2 Global Human Oocyte Cryopreservation Growth Trends by Region
2.2.1 Global Human Oocyte Cryopreservation Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Human Oocyte Cryopreservation Historic Market Size by Region (2020-2025)
2.2.3 Human Oocyte Cryopreservation Forecasted Market Size by Region (2026-2031)
2.3 Human Oocyte Cryopreservation Market Dynamics
2.3.1 Human Oocyte Cryopreservation Industry Trends
2.3.2 Human Oocyte Cryopreservation Market Drivers
2.3.3 Human Oocyte Cryopreservation Market Challenges
2.3.4 Human Oocyte Cryopreservation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Oocyte Cryopreservation Players by Revenue
3.1.1 Global Top Human Oocyte Cryopreservation Players by Revenue (2020-2025)
3.1.2 Global Human Oocyte Cryopreservation Revenue Market Share by Players (2020-2025)
3.2 Global Top Human Oocyte Cryopreservation Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Human Oocyte Cryopreservation Revenue
3.4 Global Human Oocyte Cryopreservation Market Concentration Ratio
3.4.1 Global Human Oocyte Cryopreservation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Oocyte Cryopreservation Revenue in 2024
3.5 Global Key Players of Human Oocyte Cryopreservation Head office and Area Served
3.6 Global Key Players of Human Oocyte Cryopreservation, Product and Application
3.7 Global Key Players of Human Oocyte Cryopreservation, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Oocyte Cryopreservation Breakdown Data by Type
4.1 Global Human Oocyte Cryopreservation Historic Market Size by Type (2020-2025)
4.2 Global Human Oocyte Cryopreservation Forecasted Market Size by Type (2026-2031)
5 Human Oocyte Cryopreservation Breakdown Data by Application
5.1 Global Human Oocyte Cryopreservation Historic Market Size by Application (2020-2025)
5.2 Global Human Oocyte Cryopreservation Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Human Oocyte Cryopreservation Market Size (2020-2031)
6.2 North America Human Oocyte Cryopreservation Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Human Oocyte Cryopreservation Market Size by Country (2020-2025)
6.4 North America Human Oocyte Cryopreservation Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Human Oocyte Cryopreservation Market Size (2020-2031)
7.2 Europe Human Oocyte Cryopreservation Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Human Oocyte Cryopreservation Market Size by Country (2020-2025)
7.4 Europe Human Oocyte Cryopreservation Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Human Oocyte Cryopreservation Market Size (2020-2031)
8.2 Asia-Pacific Human Oocyte Cryopreservation Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Human Oocyte Cryopreservation Market Size by Region (2020-2025)
8.4 Asia-Pacific Human Oocyte Cryopreservation Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Human Oocyte Cryopreservation Market Size (2020-2031)
9.2 Latin America Human Oocyte Cryopreservation Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Human Oocyte Cryopreservation Market Size by Country (2020-2025)
9.4 Latin America Human Oocyte Cryopreservation Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Oocyte Cryopreservation Market Size (2020-2031)
10.2 Middle East & Africa Human Oocyte Cryopreservation Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Human Oocyte Cryopreservation Market Size by Country (2020-2025)
10.4 Middle East & Africa Human Oocyte Cryopreservation Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Anova Fertility
11.1.1 Anova Fertility Company Details
11.1.2 Anova Fertility Business Overview
11.1.3 Anova Fertility Human Oocyte Cryopreservation Introduction
11.1.4 Anova Fertility Revenue in Human Oocyte Cryopreservation Business (2020-2025)
11.1.5 Anova Fertility Recent Development
11.2 CCRM IVF
11.2.1 CCRM IVF Company Details
11.2.2 CCRM IVF Business Overview
11.2.3 CCRM IVF Human Oocyte Cryopreservation Introduction
11.2.4 CCRM IVF Revenue in Human Oocyte Cryopreservation Business (2020-2025)
11.2.5 CCRM IVF Recent Development
11.3 Chill
11.3.1 Chill Company Details
11.3.2 Chill Business Overview
11.3.3 Chill Human Oocyte Cryopreservation Introduction
11.3.4 Chill Revenue in Human Oocyte Cryopreservation Business (2020-2025)
11.3.5 Chill Recent Development
11.4 CREATE Fertility
11.4.1 CREATE Fertility Company Details
11.4.2 CREATE Fertility Business Overview
11.4.3 CREATE Fertility Human Oocyte Cryopreservation Introduction
11.4.4 CREATE Fertility Revenue in Human Oocyte Cryopreservation Business (2020-2025)
11.4.5 CREATE Fertility Recent Development
11.5 Extend Fertility
11.5.1 Extend Fertility Company Details
11.5.2 Extend Fertility Business Overview
11.5.3 Extend Fertility Human Oocyte Cryopreservation Introduction
11.5.4 Extend Fertility Revenue in Human Oocyte Cryopreservation Business (2020-2025)
11.5.5 Extend Fertility Recent Development
11.6 HRC Fertility
11.6.1 HRC Fertility Company Details
11.6.2 HRC Fertility Business Overview
11.6.3 HRC Fertility Human Oocyte Cryopreservation Introduction
11.6.4 HRC Fertility Revenue in Human Oocyte Cryopreservation Business (2020-2025)
11.6.5 HRC Fertility Recent Development
11.7 IVF Australia
11.7.1 IVF Australia Company Details
11.7.2 IVF Australia Business Overview
11.7.3 IVF Australia Human Oocyte Cryopreservation Introduction
11.7.4 IVF Australia Revenue in Human Oocyte Cryopreservation Business (2020-2025)
11.7.5 IVF Australia Recent Development
11.8 Kindbody
11.8.1 Kindbody Company Details
11.8.2 Kindbody Business Overview
11.8.3 Kindbody Human Oocyte Cryopreservation Introduction
11.8.4 Kindbody Revenue in Human Oocyte Cryopreservation Business (2020-2025)
11.8.5 Kindbody Recent Development
11.9 London Women’s Clinic
11.9.1 London Women’s Clinic Company Details
11.9.2 London Women’s Clinic Business Overview
11.9.3 London Women’s Clinic Human Oocyte Cryopreservation Introduction
11.9.4 London Women’s Clinic Revenue in Human Oocyte Cryopreservation Business (2020-2025)
11.9.5 London Women’s Clinic Recent Development
11.10 Manchester Fertility
11.10.1 Manchester Fertility Company Details
11.10.2 Manchester Fertility Business Overview
11.10.3 Manchester Fertility Human Oocyte Cryopreservation Introduction
11.10.4 Manchester Fertility Revenue in Human Oocyte Cryopreservation Business (2020-2025)
11.10.5 Manchester Fertility Recent Development
11.11 Mayo Clinic
11.11.1 Mayo Clinic Company Details
11.11.2 Mayo Clinic Business Overview
11.11.3 Mayo Clinic Human Oocyte Cryopreservation Introduction
11.11.4 Mayo Clinic Revenue in Human Oocyte Cryopreservation Business (2020-2025)
11.11.5 Mayo Clinic Recent Development
11.12 Melbourne IVF
11.12.1 Melbourne IVF Company Details
11.12.2 Melbourne IVF Business Overview
11.12.3 Melbourne IVF Human Oocyte Cryopreservation Introduction
11.12.4 Melbourne IVF Revenue in Human Oocyte Cryopreservation Business (2020-2025)
11.12.5 Melbourne IVF Recent Development
11.13 Monash IVF
11.13.1 Monash IVF Company Details
11.13.2 Monash IVF Business Overview
11.13.3 Monash IVF Human Oocyte Cryopreservation Introduction
11.13.4 Monash IVF Revenue in Human Oocyte Cryopreservation Business (2020-2025)
11.13.5 Monash IVF Recent Development
11.14 Pacific Fertility Center-Los Angeles (PFCLA)
11.14.1 Pacific Fertility Center-Los Angeles (PFCLA) Company Details
11.14.2 Pacific Fertility Center-Los Angeles (PFCLA) Business Overview
11.14.3 Pacific Fertility Center-Los Angeles (PFCLA) Human Oocyte Cryopreservation Introduction
11.14.4 Pacific Fertility Center-Los Angeles (PFCLA) Revenue in Human Oocyte Cryopreservation Business (2020-2025)
11.14.5 Pacific Fertility Center-Los Angeles (PFCLA) Recent Development
11.15 PIVET
11.15.1 PIVET Company Details
11.15.2 PIVET Business Overview
11.15.3 PIVET Human Oocyte Cryopreservation Introduction
11.15.4 PIVET Revenue in Human Oocyte Cryopreservation Business (2020-2025)
11.15.5 PIVET Recent Development
11.16 Prelude Fertility
11.16.1 Prelude Fertility Company Details
11.16.2 Prelude Fertility Business Overview
11.16.3 Prelude Fertility Human Oocyte Cryopreservation Introduction
11.16.4 Prelude Fertility Revenue in Human Oocyte Cryopreservation Business (2020-2025)
11.16.5 Prelude Fertility Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Human Oocyte Cryopreservation Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Slow-cooling Method
Table 3. Key Players of Flash-freezing Process (Vitrification)
Table 4. Global Human Oocyte Cryopreservation Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Human Oocyte Cryopreservation Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Human Oocyte Cryopreservation Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Human Oocyte Cryopreservation Market Share by Region (2020-2025)
Table 8. Global Human Oocyte Cryopreservation Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Human Oocyte Cryopreservation Market Share by Region (2026-2031)
Table 10. Human Oocyte Cryopreservation Market Trends
Table 11. Human Oocyte Cryopreservation Market Drivers
Table 12. Human Oocyte Cryopreservation Market Challenges
Table 13. Human Oocyte Cryopreservation Market Restraints
Table 14. Global Human Oocyte Cryopreservation Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Human Oocyte Cryopreservation Market Share by Players (2020-2025)
Table 16. Global Top Human Oocyte Cryopreservation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Oocyte Cryopreservation as of 2024)
Table 17. Ranking of Global Top Human Oocyte Cryopreservation Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Human Oocyte Cryopreservation Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Human Oocyte Cryopreservation, Headquarters and Area Served
Table 20. Global Key Players of Human Oocyte Cryopreservation, Product and Application
Table 21. Global Key Players of Human Oocyte Cryopreservation, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Human Oocyte Cryopreservation Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Human Oocyte Cryopreservation Revenue Market Share by Type (2020-2025)
Table 25. Global Human Oocyte Cryopreservation Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Human Oocyte Cryopreservation Revenue Market Share by Type (2026-2031)
Table 27. Global Human Oocyte Cryopreservation Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Human Oocyte Cryopreservation Revenue Market Share by Application (2020-2025)
Table 29. Global Human Oocyte Cryopreservation Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Human Oocyte Cryopreservation Revenue Market Share by Application (2026-2031)
Table 31. North America Human Oocyte Cryopreservation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Human Oocyte Cryopreservation Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Human Oocyte Cryopreservation Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Human Oocyte Cryopreservation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Human Oocyte Cryopreservation Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Human Oocyte Cryopreservation Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Human Oocyte Cryopreservation Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Human Oocyte Cryopreservation Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Human Oocyte Cryopreservation Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Human Oocyte Cryopreservation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Human Oocyte Cryopreservation Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Human Oocyte Cryopreservation Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Human Oocyte Cryopreservation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Human Oocyte Cryopreservation Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Human Oocyte Cryopreservation Market Size by Country (2026-2031) & (US$ Million)
Table 46. Anova Fertility Company Details
Table 47. Anova Fertility Business Overview
Table 48. Anova Fertility Human Oocyte Cryopreservation Product
Table 49. Anova Fertility Revenue in Human Oocyte Cryopreservation Business (2020-2025) & (US$ Million)
Table 50. Anova Fertility Recent Development
Table 51. CCRM IVF Company Details
Table 52. CCRM IVF Business Overview
Table 53. CCRM IVF Human Oocyte Cryopreservation Product
Table 54. CCRM IVF Revenue in Human Oocyte Cryopreservation Business (2020-2025) & (US$ Million)
Table 55. CCRM IVF Recent Development
Table 56. Chill Company Details
Table 57. Chill Business Overview
Table 58. Chill Human Oocyte Cryopreservation Product
Table 59. Chill Revenue in Human Oocyte Cryopreservation Business (2020-2025) & (US$ Million)
Table 60. Chill Recent Development
Table 61. CREATE Fertility Company Details
Table 62. CREATE Fertility Business Overview
Table 63. CREATE Fertility Human Oocyte Cryopreservation Product
Table 64. CREATE Fertility Revenue in Human Oocyte Cryopreservation Business (2020-2025) & (US$ Million)
Table 65. CREATE Fertility Recent Development
Table 66. Extend Fertility Company Details
Table 67. Extend Fertility Business Overview
Table 68. Extend Fertility Human Oocyte Cryopreservation Product
Table 69. Extend Fertility Revenue in Human Oocyte Cryopreservation Business (2020-2025) & (US$ Million)
Table 70. Extend Fertility Recent Development
Table 71. HRC Fertility Company Details
Table 72. HRC Fertility Business Overview
Table 73. HRC Fertility Human Oocyte Cryopreservation Product
Table 74. HRC Fertility Revenue in Human Oocyte Cryopreservation Business (2020-2025) & (US$ Million)
Table 75. HRC Fertility Recent Development
Table 76. IVF Australia Company Details
Table 77. IVF Australia Business Overview
Table 78. IVF Australia Human Oocyte Cryopreservation Product
Table 79. IVF Australia Revenue in Human Oocyte Cryopreservation Business (2020-2025) & (US$ Million)
Table 80. IVF Australia Recent Development
Table 81. Kindbody Company Details
Table 82. Kindbody Business Overview
Table 83. Kindbody Human Oocyte Cryopreservation Product
Table 84. Kindbody Revenue in Human Oocyte Cryopreservation Business (2020-2025) & (US$ Million)
Table 85. Kindbody Recent Development
Table 86. London Women’s Clinic Company Details
Table 87. London Women’s Clinic Business Overview
Table 88. London Women’s Clinic Human Oocyte Cryopreservation Product
Table 89. London Women’s Clinic Revenue in Human Oocyte Cryopreservation Business (2020-2025) & (US$ Million)
Table 90. London Women’s Clinic Recent Development
Table 91. Manchester Fertility Company Details
Table 92. Manchester Fertility Business Overview
Table 93. Manchester Fertility Human Oocyte Cryopreservation Product
Table 94. Manchester Fertility Revenue in Human Oocyte Cryopreservation Business (2020-2025) & (US$ Million)
Table 95. Manchester Fertility Recent Development
Table 96. Mayo Clinic Company Details
Table 97. Mayo Clinic Business Overview
Table 98. Mayo Clinic Human Oocyte Cryopreservation Product
Table 99. Mayo Clinic Revenue in Human Oocyte Cryopreservation Business (2020-2025) & (US$ Million)
Table 100. Mayo Clinic Recent Development
Table 101. Melbourne IVF Company Details
Table 102. Melbourne IVF Business Overview
Table 103. Melbourne IVF Human Oocyte Cryopreservation Product
Table 104. Melbourne IVF Revenue in Human Oocyte Cryopreservation Business (2020-2025) & (US$ Million)
Table 105. Melbourne IVF Recent Development
Table 106. Monash IVF Company Details
Table 107. Monash IVF Business Overview
Table 108. Monash IVF Human Oocyte Cryopreservation Product
Table 109. Monash IVF Revenue in Human Oocyte Cryopreservation Business (2020-2025) & (US$ Million)
Table 110. Monash IVF Recent Development
Table 111. Pacific Fertility Center-Los Angeles (PFCLA) Company Details
Table 112. Pacific Fertility Center-Los Angeles (PFCLA) Business Overview
Table 113. Pacific Fertility Center-Los Angeles (PFCLA) Human Oocyte Cryopreservation Product
Table 114. Pacific Fertility Center-Los Angeles (PFCLA) Revenue in Human Oocyte Cryopreservation Business (2020-2025) & (US$ Million)
Table 115. Pacific Fertility Center-Los Angeles (PFCLA) Recent Development
Table 116. PIVET Company Details
Table 117. PIVET Business Overview
Table 118. PIVET Human Oocyte Cryopreservation Product
Table 119. PIVET Revenue in Human Oocyte Cryopreservation Business (2020-2025) & (US$ Million)
Table 120. PIVET Recent Development
Table 121. Prelude Fertility Company Details
Table 122. Prelude Fertility Business Overview
Table 123. Prelude Fertility Human Oocyte Cryopreservation Product
Table 124. Prelude Fertility Revenue in Human Oocyte Cryopreservation Business (2020-2025) & (US$ Million)
Table 125. Prelude Fertility Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
Table 129. Authors List of This Report
List of Figures
Figure 1. Human Oocyte Cryopreservation Picture
Figure 2. Global Human Oocyte Cryopreservation Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Human Oocyte Cryopreservation Market Share by Type: 2024 VS 2031
Figure 4. Slow-cooling Method Features
Figure 5. Flash-freezing Process (Vitrification) Features
Figure 6. Global Human Oocyte Cryopreservation Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Human Oocyte Cryopreservation Market Share by Application: 2024 VS 2031
Figure 8. 25-30 Year Old Female Case Studies
Figure 9. 30-35 Year Old Female Case Studies
Figure 10. 35-40 Year Old Female Case Studies
Figure 11. Others Case Studies
Figure 12. Human Oocyte Cryopreservation Report Years Considered
Figure 13. Global Human Oocyte Cryopreservation Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Human Oocyte Cryopreservation Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Human Oocyte Cryopreservation Market Share by Region: 2024 VS 2031
Figure 16. Global Human Oocyte Cryopreservation Market Share by Players in 2024
Figure 17. Global Human Oocyte Cryopreservation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Human Oocyte Cryopreservation Revenue in 2024
Figure 19. North America Human Oocyte Cryopreservation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Human Oocyte Cryopreservation Market Share by Country (2020-2031)
Figure 21. United States Human Oocyte Cryopreservation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Human Oocyte Cryopreservation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Human Oocyte Cryopreservation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Human Oocyte Cryopreservation Market Share by Country (2020-2031)
Figure 25. Germany Human Oocyte Cryopreservation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Human Oocyte Cryopreservation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Human Oocyte Cryopreservation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Human Oocyte Cryopreservation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Human Oocyte Cryopreservation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Ireland Human Oocyte Cryopreservation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Human Oocyte Cryopreservation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Human Oocyte Cryopreservation Market Share by Region (2020-2031)
Figure 33. China Human Oocyte Cryopreservation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Human Oocyte Cryopreservation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Human Oocyte Cryopreservation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Human Oocyte Cryopreservation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Human Oocyte Cryopreservation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia & New Zealand Human Oocyte Cryopreservation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Human Oocyte Cryopreservation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Human Oocyte Cryopreservation Market Share by Country (2020-2031)
Figure 41. Mexico Human Oocyte Cryopreservation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Human Oocyte Cryopreservation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Human Oocyte Cryopreservation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Human Oocyte Cryopreservation Market Share by Country (2020-2031)
Figure 45. Israel Human Oocyte Cryopreservation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Human Oocyte Cryopreservation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Human Oocyte Cryopreservation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Anova Fertility Revenue Growth Rate in Human Oocyte Cryopreservation Business (2020-2025)
Figure 49. CCRM IVF Revenue Growth Rate in Human Oocyte Cryopreservation Business (2020-2025)
Figure 50. Chill Revenue Growth Rate in Human Oocyte Cryopreservation Business (2020-2025)
Figure 51. CREATE Fertility Revenue Growth Rate in Human Oocyte Cryopreservation Business (2020-2025)
Figure 52. Extend Fertility Revenue Growth Rate in Human Oocyte Cryopreservation Business (2020-2025)
Figure 53. HRC Fertility Revenue Growth Rate in Human Oocyte Cryopreservation Business (2020-2025)
Figure 54. IVF Australia Revenue Growth Rate in Human Oocyte Cryopreservation Business (2020-2025)
Figure 55. Kindbody Revenue Growth Rate in Human Oocyte Cryopreservation Business (2020-2025)
Figure 56. London Women’s Clinic Revenue Growth Rate in Human Oocyte Cryopreservation Business (2020-2025)
Figure 57. Manchester Fertility Revenue Growth Rate in Human Oocyte Cryopreservation Business (2020-2025)
Figure 58. Mayo Clinic Revenue Growth Rate in Human Oocyte Cryopreservation Business (2020-2025)
Figure 59. Melbourne IVF Revenue Growth Rate in Human Oocyte Cryopreservation Business (2020-2025)
Figure 60. Monash IVF Revenue Growth Rate in Human Oocyte Cryopreservation Business (2020-2025)
Figure 61. Pacific Fertility Center-Los Angeles (PFCLA) Revenue Growth Rate in Human Oocyte Cryopreservation Business (2020-2025)
Figure 62. PIVET Revenue Growth Rate in Human Oocyte Cryopreservation Business (2020-2025)
Figure 63. Prelude Fertility Revenue Growth Rate in Human Oocyte Cryopreservation Business (2020-2025)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Table 1. Global Human Oocyte Cryopreservation Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Slow-cooling Method
Table 3. Key Players of Flash-freezing Process (Vitrification)
Table 4. Global Human Oocyte Cryopreservation Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Human Oocyte Cryopreservation Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Human Oocyte Cryopreservation Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Human Oocyte Cryopreservation Market Share by Region (2020-2025)
Table 8. Global Human Oocyte Cryopreservation Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Human Oocyte Cryopreservation Market Share by Region (2026-2031)
Table 10. Human Oocyte Cryopreservation Market Trends
Table 11. Human Oocyte Cryopreservation Market Drivers
Table 12. Human Oocyte Cryopreservation Market Challenges
Table 13. Human Oocyte Cryopreservation Market Restraints
Table 14. Global Human Oocyte Cryopreservation Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Human Oocyte Cryopreservation Market Share by Players (2020-2025)
Table 16. Global Top Human Oocyte Cryopreservation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Oocyte Cryopreservation as of 2024)
Table 17. Ranking of Global Top Human Oocyte Cryopreservation Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Human Oocyte Cryopreservation Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Human Oocyte Cryopreservation, Headquarters and Area Served
Table 20. Global Key Players of Human Oocyte Cryopreservation, Product and Application
Table 21. Global Key Players of Human Oocyte Cryopreservation, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Human Oocyte Cryopreservation Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Human Oocyte Cryopreservation Revenue Market Share by Type (2020-2025)
Table 25. Global Human Oocyte Cryopreservation Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Human Oocyte Cryopreservation Revenue Market Share by Type (2026-2031)
Table 27. Global Human Oocyte Cryopreservation Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Human Oocyte Cryopreservation Revenue Market Share by Application (2020-2025)
Table 29. Global Human Oocyte Cryopreservation Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Human Oocyte Cryopreservation Revenue Market Share by Application (2026-2031)
Table 31. North America Human Oocyte Cryopreservation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Human Oocyte Cryopreservation Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Human Oocyte Cryopreservation Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Human Oocyte Cryopreservation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Human Oocyte Cryopreservation Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Human Oocyte Cryopreservation Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Human Oocyte Cryopreservation Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Human Oocyte Cryopreservation Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Human Oocyte Cryopreservation Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Human Oocyte Cryopreservation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Human Oocyte Cryopreservation Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Human Oocyte Cryopreservation Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Human Oocyte Cryopreservation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Human Oocyte Cryopreservation Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Human Oocyte Cryopreservation Market Size by Country (2026-2031) & (US$ Million)
Table 46. Anova Fertility Company Details
Table 47. Anova Fertility Business Overview
Table 48. Anova Fertility Human Oocyte Cryopreservation Product
Table 49. Anova Fertility Revenue in Human Oocyte Cryopreservation Business (2020-2025) & (US$ Million)
Table 50. Anova Fertility Recent Development
Table 51. CCRM IVF Company Details
Table 52. CCRM IVF Business Overview
Table 53. CCRM IVF Human Oocyte Cryopreservation Product
Table 54. CCRM IVF Revenue in Human Oocyte Cryopreservation Business (2020-2025) & (US$ Million)
Table 55. CCRM IVF Recent Development
Table 56. Chill Company Details
Table 57. Chill Business Overview
Table 58. Chill Human Oocyte Cryopreservation Product
Table 59. Chill Revenue in Human Oocyte Cryopreservation Business (2020-2025) & (US$ Million)
Table 60. Chill Recent Development
Table 61. CREATE Fertility Company Details
Table 62. CREATE Fertility Business Overview
Table 63. CREATE Fertility Human Oocyte Cryopreservation Product
Table 64. CREATE Fertility Revenue in Human Oocyte Cryopreservation Business (2020-2025) & (US$ Million)
Table 65. CREATE Fertility Recent Development
Table 66. Extend Fertility Company Details
Table 67. Extend Fertility Business Overview
Table 68. Extend Fertility Human Oocyte Cryopreservation Product
Table 69. Extend Fertility Revenue in Human Oocyte Cryopreservation Business (2020-2025) & (US$ Million)
Table 70. Extend Fertility Recent Development
Table 71. HRC Fertility Company Details
Table 72. HRC Fertility Business Overview
Table 73. HRC Fertility Human Oocyte Cryopreservation Product
Table 74. HRC Fertility Revenue in Human Oocyte Cryopreservation Business (2020-2025) & (US$ Million)
Table 75. HRC Fertility Recent Development
Table 76. IVF Australia Company Details
Table 77. IVF Australia Business Overview
Table 78. IVF Australia Human Oocyte Cryopreservation Product
Table 79. IVF Australia Revenue in Human Oocyte Cryopreservation Business (2020-2025) & (US$ Million)
Table 80. IVF Australia Recent Development
Table 81. Kindbody Company Details
Table 82. Kindbody Business Overview
Table 83. Kindbody Human Oocyte Cryopreservation Product
Table 84. Kindbody Revenue in Human Oocyte Cryopreservation Business (2020-2025) & (US$ Million)
Table 85. Kindbody Recent Development
Table 86. London Women’s Clinic Company Details
Table 87. London Women’s Clinic Business Overview
Table 88. London Women’s Clinic Human Oocyte Cryopreservation Product
Table 89. London Women’s Clinic Revenue in Human Oocyte Cryopreservation Business (2020-2025) & (US$ Million)
Table 90. London Women’s Clinic Recent Development
Table 91. Manchester Fertility Company Details
Table 92. Manchester Fertility Business Overview
Table 93. Manchester Fertility Human Oocyte Cryopreservation Product
Table 94. Manchester Fertility Revenue in Human Oocyte Cryopreservation Business (2020-2025) & (US$ Million)
Table 95. Manchester Fertility Recent Development
Table 96. Mayo Clinic Company Details
Table 97. Mayo Clinic Business Overview
Table 98. Mayo Clinic Human Oocyte Cryopreservation Product
Table 99. Mayo Clinic Revenue in Human Oocyte Cryopreservation Business (2020-2025) & (US$ Million)
Table 100. Mayo Clinic Recent Development
Table 101. Melbourne IVF Company Details
Table 102. Melbourne IVF Business Overview
Table 103. Melbourne IVF Human Oocyte Cryopreservation Product
Table 104. Melbourne IVF Revenue in Human Oocyte Cryopreservation Business (2020-2025) & (US$ Million)
Table 105. Melbourne IVF Recent Development
Table 106. Monash IVF Company Details
Table 107. Monash IVF Business Overview
Table 108. Monash IVF Human Oocyte Cryopreservation Product
Table 109. Monash IVF Revenue in Human Oocyte Cryopreservation Business (2020-2025) & (US$ Million)
Table 110. Monash IVF Recent Development
Table 111. Pacific Fertility Center-Los Angeles (PFCLA) Company Details
Table 112. Pacific Fertility Center-Los Angeles (PFCLA) Business Overview
Table 113. Pacific Fertility Center-Los Angeles (PFCLA) Human Oocyte Cryopreservation Product
Table 114. Pacific Fertility Center-Los Angeles (PFCLA) Revenue in Human Oocyte Cryopreservation Business (2020-2025) & (US$ Million)
Table 115. Pacific Fertility Center-Los Angeles (PFCLA) Recent Development
Table 116. PIVET Company Details
Table 117. PIVET Business Overview
Table 118. PIVET Human Oocyte Cryopreservation Product
Table 119. PIVET Revenue in Human Oocyte Cryopreservation Business (2020-2025) & (US$ Million)
Table 120. PIVET Recent Development
Table 121. Prelude Fertility Company Details
Table 122. Prelude Fertility Business Overview
Table 123. Prelude Fertility Human Oocyte Cryopreservation Product
Table 124. Prelude Fertility Revenue in Human Oocyte Cryopreservation Business (2020-2025) & (US$ Million)
Table 125. Prelude Fertility Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
Table 129. Authors List of This Report
List of Figures
Figure 1. Human Oocyte Cryopreservation Picture
Figure 2. Global Human Oocyte Cryopreservation Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Human Oocyte Cryopreservation Market Share by Type: 2024 VS 2031
Figure 4. Slow-cooling Method Features
Figure 5. Flash-freezing Process (Vitrification) Features
Figure 6. Global Human Oocyte Cryopreservation Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Human Oocyte Cryopreservation Market Share by Application: 2024 VS 2031
Figure 8. 25-30 Year Old Female Case Studies
Figure 9. 30-35 Year Old Female Case Studies
Figure 10. 35-40 Year Old Female Case Studies
Figure 11. Others Case Studies
Figure 12. Human Oocyte Cryopreservation Report Years Considered
Figure 13. Global Human Oocyte Cryopreservation Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Human Oocyte Cryopreservation Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Human Oocyte Cryopreservation Market Share by Region: 2024 VS 2031
Figure 16. Global Human Oocyte Cryopreservation Market Share by Players in 2024
Figure 17. Global Human Oocyte Cryopreservation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Human Oocyte Cryopreservation Revenue in 2024
Figure 19. North America Human Oocyte Cryopreservation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Human Oocyte Cryopreservation Market Share by Country (2020-2031)
Figure 21. United States Human Oocyte Cryopreservation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Human Oocyte Cryopreservation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Human Oocyte Cryopreservation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Human Oocyte Cryopreservation Market Share by Country (2020-2031)
Figure 25. Germany Human Oocyte Cryopreservation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Human Oocyte Cryopreservation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Human Oocyte Cryopreservation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Human Oocyte Cryopreservation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Human Oocyte Cryopreservation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Ireland Human Oocyte Cryopreservation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Human Oocyte Cryopreservation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Human Oocyte Cryopreservation Market Share by Region (2020-2031)
Figure 33. China Human Oocyte Cryopreservation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Human Oocyte Cryopreservation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Human Oocyte Cryopreservation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Human Oocyte Cryopreservation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Human Oocyte Cryopreservation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia & New Zealand Human Oocyte Cryopreservation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Human Oocyte Cryopreservation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Human Oocyte Cryopreservation Market Share by Country (2020-2031)
Figure 41. Mexico Human Oocyte Cryopreservation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Human Oocyte Cryopreservation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Human Oocyte Cryopreservation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Human Oocyte Cryopreservation Market Share by Country (2020-2031)
Figure 45. Israel Human Oocyte Cryopreservation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Human Oocyte Cryopreservation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Human Oocyte Cryopreservation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Anova Fertility Revenue Growth Rate in Human Oocyte Cryopreservation Business (2020-2025)
Figure 49. CCRM IVF Revenue Growth Rate in Human Oocyte Cryopreservation Business (2020-2025)
Figure 50. Chill Revenue Growth Rate in Human Oocyte Cryopreservation Business (2020-2025)
Figure 51. CREATE Fertility Revenue Growth Rate in Human Oocyte Cryopreservation Business (2020-2025)
Figure 52. Extend Fertility Revenue Growth Rate in Human Oocyte Cryopreservation Business (2020-2025)
Figure 53. HRC Fertility Revenue Growth Rate in Human Oocyte Cryopreservation Business (2020-2025)
Figure 54. IVF Australia Revenue Growth Rate in Human Oocyte Cryopreservation Business (2020-2025)
Figure 55. Kindbody Revenue Growth Rate in Human Oocyte Cryopreservation Business (2020-2025)
Figure 56. London Women’s Clinic Revenue Growth Rate in Human Oocyte Cryopreservation Business (2020-2025)
Figure 57. Manchester Fertility Revenue Growth Rate in Human Oocyte Cryopreservation Business (2020-2025)
Figure 58. Mayo Clinic Revenue Growth Rate in Human Oocyte Cryopreservation Business (2020-2025)
Figure 59. Melbourne IVF Revenue Growth Rate in Human Oocyte Cryopreservation Business (2020-2025)
Figure 60. Monash IVF Revenue Growth Rate in Human Oocyte Cryopreservation Business (2020-2025)
Figure 61. Pacific Fertility Center-Los Angeles (PFCLA) Revenue Growth Rate in Human Oocyte Cryopreservation Business (2020-2025)
Figure 62. PIVET Revenue Growth Rate in Human Oocyte Cryopreservation Business (2020-2025)
Figure 63. Prelude Fertility Revenue Growth Rate in Human Oocyte Cryopreservation Business (2020-2025)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global UV Delayed Curing Adhesives Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Global Die-Casting Die Steel Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Global Adaptive Neuromodulation Therapy Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232